- Home
- ELEV vs ABVC Comparison
ELEV vs ABVC Comparison
Compare ELEV & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- ABVC
- Stock Information
- Founded
- ELEV 2019
- ABVC 2015
- Country
- ELEV United States
- ABVC United States
- Employees
- ELEV N/A
- ABVC N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- ELEV Health Care
- ABVC Health Care
- Exchange
- ELEV Nasdaq
- ABVC Nasdaq
- Market Cap
- ELEV 20.0M
- ABVC 18.8M
- IPO Year
- ELEV 2021
- ABVC N/A
- Fundamental
- Price
- ELEV $0.34
- ABVC $1.46
- Analyst Decision
- ELEV Buy
- ABVC
- Analyst Count
- ELEV 6
- ABVC 0
- Target Price
- ELEV $2.94
- ABVC N/A
- AVG Volume (30 Days)
- ELEV 975.2K
- ABVC 248.3K
- Earning Date
- ELEV 05-23-2025
- ABVC 04-30-2025
- Dividend Yield
- ELEV N/A
- ABVC N/A
- EPS Growth
- ELEV N/A
- ABVC N/A
- EPS
- ELEV N/A
- ABVC N/A
- Revenue
- ELEV N/A
- ABVC $508,383.00
- Revenue This Year
- ELEV N/A
- ABVC $735.18
- Revenue Next Year
- ELEV N/A
- ABVC N/A
- P/E Ratio
- ELEV N/A
- ABVC N/A
- Revenue Growth
- ELEV N/A
- ABVC 1904.43
- 52 Week Low
- ELEV $0.22
- ABVC $0.40
- 52 Week High
- ELEV $4.33
- ABVC $1.40
- Technical
- Relative Strength Index (RSI)
- ELEV 48.18
- ABVC 64.11
- Support Level
- ELEV $0.33
- ABVC $1.18
- Resistance Level
- ELEV $0.37
- ABVC $1.36
- Average True Range (ATR)
- ELEV 0.03
- ABVC 0.14
- MACD
- ELEV 0.00
- ABVC 0.05
- Stochastic Oscillator
- ELEV 25.54
- ABVC 63.74
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.